Nicole Murdock

A seasoned healthcare professional with over 20 years of experience in clinical inpatient and outpatient settings, specializing in cardiology and geriatric care. I have expertise in the areas of patient safety, HEDIS, Medicare, and Quality Improvement initiatives. Accomplished public speaker, published author, and dedicated educator with a strong leadership presence in professional organizations. Recognized for contributions to geriatric pharmacy services, clinical research, and advancing healthcare through innovation and education.

• American College of Cardiology | 2021-Current
• Arizona Geriatric Society | Board Member | 2023-Current
• American College of Clinical Pharmacy (ACCP) | Member of Internal Medicine & Cardiology Practice and Research Networks
• American Society of Health-System Pharmacists (ASHP) | 2002-current
• Arizona Pharmacist Association | Chair, Health Systems Academy | 2017-current
• Rho Chi: The Academic Honor Society of Pharmacy | 2009-Current

MANUSCRIPT PUBLICATIONS

2017 Rodrigues CR, Harrington AR, Murdock N, Holmes JT, Borzadek EZ, Calabro K, Martin J. Effect of Pharmacy-Supported Transition-of-Care Interventions on 30-Day Readmissions: A Systematic Review and Meta-analysis., Slack MK. Ann Pharmacother. 2017 Jun 1:1060028017712725. doi: 10.1177/1060028017712725. [Epub ahead of print] PMID:28599601

2014 Weissig V, Pettinger TK, Murdock N. Int J Nanomedicine. 2014 Sep 15;9:4357-73. doi: 10.2147/IJN.S46900. eCollection 2014. Nanopharmaceuticals (part 1): products on the market.

2008 Murdock N, Solbrig R, Liday C. Benign Prostatic Hyperplasia: Pharmacotherapy in Primary Care, 1st ed. Linn W, Wofford M, O’Keefe M, Posey L, et al (eds.): New York, McGraw Hill, 2008. pp.337-345.

2007 Baker N, Murdock N, Pugmire B. Lovaza®: Potent, pure, and proven? Evidence-Based Practice 2007; 11(3):10-11.

2007 Gomes M, Murdock N, Korasick J. Transdermal methylphenidate effective for ADHD? Evidence-Based Practice 2007; 10(11): 10-11.

2007 Owens K, Murdock N. Safety of long-acting Beta 2 agonists in asthma. Evidence-Based Practice 2007; 10(10): 10-12.

2007 Taylor A, Murdock N. Does Paxil CR pan out? Evidence-Based Practice 2007; 10(4): 10-11.

2007 Kowitz M, Murdock N. Osteonecrosis of the jaw: The Risk with oral bisphosphonates. Evidence-Based Practice 2007; 10(2): 10-11.

2006 Watts J, Murdock N. Zegerid®: Old Dog, New Tricks? Evidence-Based Practice 2006; 9(12): 10-11.

2006 Nulph C, Murdock N, Liday C. Pramlintide (Symlin®): Postprandial help for patients with dibetes? Evidence-Based Practice 2006; 9(5): 10-11.

2006 Murdock N, Force RW, Black M. Pregabalin: Is the Enthusiasm Premature? Evidence-Based Practice 2006; 9(4):10-12.

2004 Murdock N, Owens CT. Statins: Just another tool in the Shed? DUR Discovery, Winter newsletter, February 2004.

2004 Murdock N, Owens CT. Oral Opiods for Chronic Non-Malinant Pain. DUR Discovery, Summer newsletter, July 2004.

ABSTRACTS

2021 Znbaqa M, Saeed F, Murdock N. Perceived comfort level of a pharmacist in dealing with patients at risk for drug-induced QT prolongation. Annual ASHP Meeting, 2021.

2018 Hamilton M, Ceimo J, Murdock N. Opioids in the Elderly: How much of a difference does a year make? A one-year follow up on prescribing patterns in one geriatric medical inpatient center after multiple education sessions and legislative changes made. Banner Health and University of Arizona’s Annual Quality and Safety Day for Medical Residents and Fellows, Phoenix, AZ

2018 Adekunle A, Ceimo J, Murdock N. Hoofbeats: Horses vs. Zebras. A case report on a 71 year old female presenting with subacute neuropsychiatric symptoms.

2017 Griffin P, Cottom R, Murdock N. Evaluation of risk factors for coronary stent restenosis or thrombosis within one year of stent placement. Annual ASHP Midyear Clinical Meeting & Exhibition, Orlando, Florida.

2017 Reddy S, Ceimo J, Murdock N. A qualitative review of opioid use in a geriatric population with and without lung disease. Banner Health and University of Arizona’s Annual Quality and Safety Day for Medical Residents and Fellows, Phoenix, AZ. (Second Place Awarded)

2016 Russel K, Murdock N, Cottam R. A retrospective, qualitative review of the enhanced care process of the HEART pathway tool in a geriatric population. Annual ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.

2016 Nguyen T, Saadeh D, Leong S, Murdock N, Tsu L, Liu K, Nemeth R.(2016) Implementation of a pharmacist-driven training program for medical assistants on comprehensive medication history in a cardiology clinic. Annual ACCP meeting, San Francisco, CA.

2016 Harrington A, Rodriguez C, Murdock N, Holmes J, Borzadek E, Calabro K, Martin J, Slack M. Effect of Pharmacist-Supported Transition-of-Care Program on 30-Day Readmission Rates: A Systematic Review and Meta-Analysis. Submitted and presented at AMCP April 2016.

2015 Rodriguez C, Murdock N, Holms J, Borzadek E, Calabro K. Systematic review of post-hospital discharge outcomes associated with pharmacy-related interventions at transitions of care in the United States. Submitted and accepted for poster presentation at AMCP’s 27th Annual Meeting and Expo April 2015 San Diego, CA.

2014 Remigio A, Gohil K, Tsu L, Murdock N, Gurney M. Evaluation of motivational interviewing series on student’s confidence level during experiential rotations. Submitted and accepted for poster presentation AzPA Annual Convention June 2014.

2014 Remigio A, Gohil K, Tsu L, Murdock N, Gurney M. Evaluation of motivational interviewing series on student’s confidence level during experiential rotations. Submitted and accepted for ACCP Virtual Poster Symposium May 2014.

2014 Truong K, Stratton S, Murdock N. Developing and evaluating a risk calculator for predicting clinically significant QT interval prolongation in hospital admitted patients. Submitted and accepted for poster presentation ASHP Midyear Convention Dec 2014

2006 Murdock N, Force RW, Woodhouse WW. The self-reported pharmaceutical industry interactions of Medicaid providers and subsequent correlations between their responses and perceptions of the pharmaceutical industry including possible influences upon prescribing patterns. Accepted for poster presentation, American College of Clinical Pharmacy 2006, Monterey, CA April 8-11

2005 Murdock N, Force RW, Woodhouse WW. Determining the influence of self-reported pharmaceutical industry interaction on the intraclass medication choice of Medicaid prescribers. Accepted for poster presentation, American College of Clinical Pharmacy 2005, Myrtle Beach, SC April 10-13.

2004 Owens CT, Cady PS, Culbertson VL, Force RW, Murdock N, Pettinger TK, and Steiner JF. Idaho Medicaid prior authorization of palivizumab (Synagis). Accepted for poster presentation, American College of Clinical Pharmacy 2005, Myrtle Beach, SC April 10-13.

2004 Murdock N, Force RW, Cady PS, Owens CT, Pettinger TK, Culbertson VL. Association of the development of hypertension among users of COX-2 inhibitors and nonselective NSAIDs. Accepted for poster presentation,

American College of Clinical Pharmacy 2004 International Congress on

Clinical Pharmacy, Paris France April 29.

2003 Murdock N, Force RW, Wilson JJW. Hormone Replacement Therapy in Idaho: A Retrospective Database Analysis Comparing HRT Trends in Relation to Megatrials & Guidelines. Accepted for poster presentation, American College of Clinical Pharmacy 2003 Congress on Clinical Pharmacy, Palm Springs, California.

2003 Murdock N, Force RW, Wilson JJW, Cady PS. Use of Survival Analysis to Evaluate Duration of HRT: Influence of Mega-Trials & Guidelines. Accepted for poster presentation, American College of Clinical Pharmacy 2003 Congress on Clinical Pharmacy, Palm Springs, California.

RESEARCH

2014-current Developing and evaluating a risk calculator for predicting clinically significant QT interval prolongation in hospital admitted patients. A prospective, observational study of QT intervals in a general hospitalized population to determine associated risk factors, stratify risk factors based on the level of risk, and finally develop and validate a tool to help determine a patient’s risk of developing QT prolongation which will help guide pharmacotherapy, electrolyte replacement, and monitoring intensity for the patient while hospitalized. Prinicpal Invesitgator: Murdock N

Co-Investigators: Raymond Woosley MD (AzCert and UofA), James Tisdale PharmD (Purdue), Will Heise MD (UofA & Banner University Medical Center), Shannon Stratton PharmD (Veterans Association Medical Center), Nate Spence PharmD (Banner Pharmacy Services Corporate)

2014-current Effect of medication reconciliation and pharmacist intervention on adherence rates. Prospective, randomized trial to determine the effect of a pharmacist managed transition of care clinic for patients recently hospitalized and adherence follow up over a 6 month period. Principal Investigator: Murdock N.

2005-2010 Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM HIGH). Co-Principal Investigator and study coordinator: Nicole Murdock. Funded by the National Heart Lung and Blood Institute. Prospective, randomized, placebo controlled lipid lowering and biomarker study for secondary prevention of coronary artery disease, cerebrovascular disease, and peripheral vascular disease. Running from 2005 to 2010.

2004 Determining the influence of self-reported pharmaceutical industry interaction on the intraclass medication choice of Medicaid prescribers. Human Subjects Committee Proposal. Principal Investigator: Rex W. Force. Co-Principal Investigator: Nicole Murdock, William W. Woodhouse.

2004 Evaluating the role a clinical pharmacist in an interdisciplinary congestive heart failure clinic in regards to patient quality of life and resident physician teaching. Human Subjects Committee Proposal. Principal Investigator: Nicole Murdock. Co-Prinicipal Investigator: Rex W. Force.

• Board Certified Pharmacotherapy Specialist (BCPS)
• Heart Failure & Transplant Training Program | University of Utah
• Executive Healthcare Delivery Improvement Program | Intermountain Healthcare
• Tobacco Cessation Program| Mayo Clinic
• Clinical Diabetes Management | International Diabetes Center

• Polypharmacy & The Life-Changing Magic of Tidying Up, Case Management Society of America, Arizona Chapter Annual Conference, Sept 2023, Delivered a compelling presentation on strategies to manage polypharmacy, emphasizing its impact on patient safety and quality of care in elderly populations.
• The Polypharmacy Pandemic: Strategies to Reduce Harm & Improve Outcomes, 25th Annual National Conduent/Midas Symposium, Tucson, AZ, 2017, Presented on the growing challenge of polypharmacy in geriatric care, outlining effective strategies for healthcare providers to minimize medication-related risks and enhance patient outcomes.
• Geriatric Psychiatric Medications, Banner University Medical Center, 2024
• Polypharmacy & The Life Changing Magic of Tidying Up, Arizona Geriatric Society Annual Conference, 2022
• Opioids in the Aging Population, Multiple Audiences: AzGS, Banner Health, National Nursing, 2017
• The Polypharmacy Pandemic, Keynote | Conduent/Midas National Symposium, 2017
• Pharmacy in Care Transitions, Keynote| Arizona Pharmacist Association Annual Convention, 2015
• Chronic Heart Failure, Keynote | Idaho Society of Health-System Pharmacists Annual Meeting, 2010

Title: PharmD, BCPS

• Top Doc of the Year: Geriatric Pharmacy Services | Scottsdale TopDoc | 2023
• Gerontologist of the Year | Arizona Geriatric Society | 2022
• Teacher of the Year | MWU College of Pharmacy | 2020
• Outstanding Leadership and Service to the Profession of Pharmacy | Phi Lambda Sigma | 2019
• Excellence in Innovation | Arizona Pharmacist Association | 2013
• Teacher of the Semester | January 2010
• Teacher of the Semester | January 2009
• Inducted to Rho Chi Honor Society for Pharmacy | 2009
• Best Resident Researcher | Pocatello Family Medicine Residency | 2005
• West Coast Intern of the Year | Rite Aid | 2002